Clinical TrialsSearch results
Number of results: 303
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-05-04
Other
- Unruptured Cerebral Aneurysm Study in Japan
- Unruptured intracranial aneurysms
- Society of Japan Neurosurgical Society
- 2006-05-17
Other
- Randomized double blind comparative study of nipradilol, an alfa-1,beta-blocker with a nitric oxide donative action, and timolol, a non-selective beta-blocker, on the visual field in Japanese patients with normal-tension glaucoma.
- Normal Tension Glaucoma
- KOWA company, ltd.
- 2006-05-25
Other
- Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients
- Metastatic or recurrent breast cancer
- SELECT BC executive committee
- 2006-06-01
Other
- Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer
- Preaviously untreated advanced advanced squamous cell lung cancer
- Department of Respiratory Medicine of Kyoto University Hospital
- 2006-07-01
Other
- Nagoya Acute Myocardial Infarction Study
- acute myocardial infarction
- Japan Heart Foundation
- 2006-07-01
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- Validation study VI of febrile neutropenia guideline 2004
- Febrile Neutropenia
- Japan Febrile Neutropenia Study Group
- 2006-08-04
Other
- Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor
- First line therapy for recurrence or metastatic postmenopausal breast cancer
- Nagoya University of School of Medicine Breast and Endocrine Surgery
- 2006-10-01
Other
- Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).
- End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)
- Nagoya University
- 2006-10-01